The federal government urged the US Supreme Court to hear an appeal from Hikma Pharmaceuticals USA Inc. challenging an ...
Pharmalittle: We’re reading about FDA plans for CAR-T therapies, skinny drug labels, and much more
In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...
In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...
Teva Pharmaceutical (TEVA) stock is in focus as the company seeks to remove over 200 improperly listed Orange Book patents ...
Shares in Sarepta reversed some of their recent declines after the FDA added a warning label to its Duchenne muscular dystrophy (DMD) gene therapy, ending a protracted period of uncertainty for the ...
Test your knowledge with this American food quiz and see if you can guess how old these iconic snacks and brands really are.
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics (NASDAQ:CVKD) believes it continues to be misread by the market. Yes, the Company is intentionally narrowly focused. Howev ...
The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the third quarter ended October ...
New Hypertension Publication Underscores Aprocitentan's Potential In Managing Hypertension Patients With CKD. <li /> New analysis from landmark Phase 3 PRECISION trial published in Hypertension highl ...
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback